In addition, the present findings may improve the efficacy of immunomodulatory therapeutic interventions as PD-L1 expression level of tumor cells is one of the most important factors to identify suitable patients for PD-1 blockade treatment [30,31]. The gene discussed is CD274; the disease is neoplasm.